47.19
price down icon6.18%   -3.11
after-market Handel nachbörslich: 47.44 0.25 +0.53%
loading

Novo Nordisk Adr Aktie (NVO) Neueste Nachrichten

pulisher
02:22 AM

Novo Nordisk Faces a Reality Check as Pricing Pressure Hits 2026 Forecasts - Investing.com

02:22 AM
pulisher
10:23 AM

NVO Q4 Earnings & Sales Beat Estimates, Stock Down on Poor 2026 View - Finviz

10:23 AM
pulisher
Feb 03, 2026

Novo Nordisk ADR earnings beat by $0.10, revenue topped estimates - Investing.com Australia

Feb 03, 2026
pulisher
Feb 03, 2026

Novo Nordisk's U.S. listing drops significantly after earnings report - medwatch.com

Feb 03, 2026
pulisher
Feb 02, 2026

Jim Cramer Believes Novo Nordisk "Is a Hold, Not a Buy" - Finviz

Feb 02, 2026
pulisher
Feb 02, 2026

Is Novo Nordisk Stock a Bargain Right Now? - Finviz

Feb 02, 2026
pulisher
Jan 31, 2026

BMO Raises Novo Nordisk A/S (NVO) Price Target but Flags Prescription Pressures - Finviz

Jan 31, 2026
pulisher
Jan 31, 2026

Should You Buy Novo Nordisk Stock on Oral Wegovy's Strong Launch? - Finviz

Jan 31, 2026
pulisher
Jan 30, 2026

Demand for Novo Nordisk's Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally? - Finviz

Jan 30, 2026
pulisher
Jan 30, 2026

Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock? - Finviz

Jan 30, 2026
pulisher
Jan 25, 2026

5 Stocks To Keep an Eye On in 2026, According to Experts - AOL.com

Jan 25, 2026
pulisher
Jan 24, 2026

Novo Nordisk’s Wegovy Pill And Akero Deal Reframe Obesity Growth Story - Sahm

Jan 24, 2026
pulisher
Jan 22, 2026

Market Trends: What is the next catalyst for ISPCRate Cut & Weekly Setup with ROI Potential - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Stock Report: Is Novo Nordisk A s b Shares Adrhedged in a consolidation phaseJuly 2025 Highlights & Real-Time Sentiment Analysis - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Novo Nordisk AS (NVO) Stock Price, Trades & News - GuruFocus

Jan 22, 2026
pulisher
Jan 22, 2026

Jim Cramer on Novo Nordisk: "I Think They're Making a Turn Here" - Finviz

Jan 22, 2026
pulisher
Jan 21, 2026

Novo Nordisk ADR: Weight?loss Champion Faces High?Altitude Turbulence - AD HOC NEWS

Jan 21, 2026
pulisher
Jan 20, 2026

Novo Nordisk Deepens Cell Therapy Push In Canada As Shares Screen Cheap - Sahm

Jan 20, 2026
pulisher
Jan 20, 2026

Key facts: Novo Nordisk stock rises 9.12%; expands diabetes partnership; launches Ozempic ad campaign - TradingView

Jan 20, 2026
pulisher
Jan 20, 2026

Is Oral Wegovy a Game Changer for Novo Nordisk? - Finviz

Jan 20, 2026
pulisher
Jan 19, 2026

Novo Nordisk A/S-Spons ADR (NYSE:NVO) Demonstrates a Strong Dividend Profile Backed by High Profitability - Chartmill

Jan 19, 2026
pulisher
Jan 18, 2026

Shorts Report: Can Novo Nordisk A s b Shares Adrhedged be the next market leader - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 16, 2026

Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? - Finviz

Jan 16, 2026
pulisher
Jan 16, 2026

Novo Nordisk (NVO) is "in a Battle," Says Jim Cramer - Finviz

Jan 16, 2026
pulisher
Jan 15, 2026

Europe’s ADR Index Was Flat, But Single Stocks Were Not - Finimize

Jan 15, 2026
pulisher
Jan 13, 2026

Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026? - Finviz

Jan 13, 2026
pulisher
Jan 13, 2026

Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026? - Finviz

Jan 13, 2026
pulisher
Jan 12, 2026

Looking At Novo Nordisk's Recent Unusual Options Activity - Sahm

Jan 12, 2026
pulisher
Jan 10, 2026

Can Novo Nordisk A s (b Shares) Adrhedged stock continue upward trendWeekly Loss Report & Daily Risk Controlled Trade Plans - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

Novo Nordisk gets a fresh $73.50 target as Amazon starts selling the Wegovy pill - TechStock²

Jan 09, 2026
pulisher
Jan 09, 2026

Novo Nordisk A/S (B Shares) ADRhedged (BATS:NVOH) Trading 0.4% Higher – What’s Next? - Defense World

Jan 09, 2026
$366.20
price up icon 8.15%
$146.23
price up icon 2.06%
drug_manufacturers_general PFE
$26.78
price up icon 3.92%
drug_manufacturers_general AZN
$187.45
price up icon 1.70%
drug_manufacturers_general NVS
$152.91
price up icon 2.04%
Kapitalisierung:     |  Volumen (24h):